×
Home Current Archive Editorial board
News Contact
Review paper

Effectiveness of teriparatide combined with the Ilizarov technique in septic tibial non-union

By
Giuseppe Rollo Orcid logo ,
Giuseppe Rollo
Contact Giuseppe Rollo

Department of Orthopaedics and Traumatology, Vito Fazzi Hospital , Lecce , Italy

Francesco Luceri ,
Francesco Luceri

Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Ortopedico Galeazzi , Milan , Italy

Gabriele Falzarano ,
Gabriele Falzarano

Department of Orthopaedics and Traumatology, AORN SAN PIO “Gaetano Rummo Hospital” , Benevento , Italy

Carlo Salomone ,
Carlo Salomone

Malattie Infettive Osteo-Articolari MIOS, S. Maria di Misericordia Hospital , Savona , Italy

Enrico Maria Bonura ,
Enrico Maria Bonura
Contact Enrico Maria Bonura

Department of Orthopaedics and Traumatology, Poliambulanza Foundation Hospital , Brescia , Italy

Dmitry Popkov ,
Dmitry Popkov

Russian Ilizarov Scientific Centre “Reconstructive Traumatology and Orthopaedics” , Kurgan , Russia

Mario Ronga ,
Mario Ronga

Department of Medicine and Health Sciences 'Vincenzo Tiberio' , University of Molise , Campobasso , Italy

Giuseppe Pica ,
Giuseppe Pica

Department of Orthopaedics and Traumatology, AORN SAN PIO “Gaetano Rummo Hospital” , Benevento , Italy

Michele Bisaccia ,
Michele Bisaccia

Division of Orthopaedics and Trauma Surgery, University of Perugia, “S. Maria della Misericordia” Hospital , Perugia , Italy

Valentina Russi ,
Valentina Russi

Department of Orthopaedics and Traumatology, Vito Fazzi Hospital , Lecce , Italy

Predrag Grubor ,
Predrag Grubor

School of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina

Raffaele Franzese ,
Raffaele Franzese

Orthopaedics and Traumatology Unit, Villa del Sole Caserta, Caserta , Caserta , Italy

Giuseppe M. Peretti ,
Giuseppe M. Peretti

Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Ortopedico Galeazzi , Milan , Italy

Department of Biomedical Sciences for Health, University of Milan , Milan , Italy

Luigi Meccariello
Luigi Meccariello

Department of Orthopaedics and Traumatology, AORN SAN PIO “Gaetano Rummo Hospital” , Benevento , Italy

Abstract

Aim
The septic non-union is a common compliance in bone healing due to bone infection. Bone resection, associated with Ilizarov osteo-distraction technique, is commonly used in these cases. The aim of this study was to analyse clinical and radiological results of teriparatide in combination with the Ilizarov technique and to compare this treatment with the standard treatment.
Methods
Forty adult patients underwent surgery because of type C of the Association for the Study and Application of Methods
of Ilizarov (ASAMI) classification non-union were enrolled. The patients were divided in two groups: those treated with Ilizarov technique (Norm group) and those treated with Ilizarov technique combined with teriparatide injection (Teri group). Surgical duration, complication rate, bone healing status, clinical and functional outcomes were assessed according to the A.S.A.M.I. classification in the mean follow-up of 12 months. The subjective quality of life was assessed by the Short Form Survey (SF)-12.
Results
Teri group showed less time wearing Ilizarov's frame (p<0.05) than the Norm group and a statistical significance in the inter-rater reliability Cohen’s k (p>0.05) respect to Norm according the score between the bone healing and clinical outcome results. There was no statistically significant difference between the two groups in other parameters that were assessed.
Conclusion
A benefit of teriparatide was found as adjuvant in the treatment of septic non-union.

References

1.
Calori G, Colombo M, Mazza E, Mazzola S, Malagoli E, Marelli N, et al. Validation of the Non-Union Scoring System in 300 long bone nonunions. Injury. 2014;(Suppl 6):93–7.
2.
Chaudhary M. Infected non-union of tibia. Indian J Orthop. 2017;256–68.
3.
Gubin A, Borzunov D, Marchenkova L, Malkova T, Smirnova I. Contribution of G.A. Ilizarov to bone reconstruction: historical achievements and state of the art. Strategies Trauma Limb Reconstr. 2016;145–52.
4.
Grubor P, Falzarano G, Grubor M, Piscopo A, Franzese R, Meccariello L. Treatment of the chronic war tibial osteomyelitis, Gustilo type IIIB and Cierny-Mader IIIB, using various methods. A Retrospective study. EMBJ. 2014;7–18.
5.
Grubor P, Milicevic S, Grubor M, Meccariello L. Treatment of bone defects in war wounds: retrospective study. Med Arh. 2015;260–4.
6.
Raghavan P, Christofides E. Role of teriparatide in accelerating metatarsal stress fracture healing: a case series and review of literature. Clin Med Insights Endocrinol Diabetes. 2012;39–45.
7.
Andreassen T, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;960–8.
8.
Aspenberg P, Genant H, Johansson T, Nino A, See K, Krohn K, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind-study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010;404–14.
9.
Yin P, Zhang Q, Mao Z, Li T, Zhang L, Tang P. The treatment of infected tibial non-union by bone transport using the Ilizarov external fixator and a systematic review of infected tibial non-union treated by Ilizarov methods. Acta Orthop Belg. 2014;426–35.
10.
Iliopoulos E, Morrissey N, Cho S, Khaleel A. Outcomes of the Ilizarov frame use in elderly patients. J Orthop Sci. 2017;783–6.
11.
Hak D. Epidemiology of fracture nonunion in 18 human bones. Ann Transl Med. 2017;(Suppl 1).
12.
Seebach C, Skripitz R, Andreassen T, Aspenberg P. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res. 2004;472–8.
13.
Peichl P, Holzer L, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;1583–7.
14.
Wagner F, Vach W, Augat P, Varady P, Panzer S, Keiser S, et al. Daily subcutaneous teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study. Injury. 2019;1478–82.
15.
Coppola C, Buono D, Maffulli A, N. Teriparatide in fracture non-unions. Transl Med UniSa. 2014;47–53.
16.
Abuomira I, Sala F, Elbatrawy Y, Lovisetti G, Alati S, Capitani D. Distraction osteogenesis for tibial nonunion with bone loss using combined Ilizarov and Taylor spatial frames versus a conventional circular frame. Strategies Trauma Limb Reconstr. 2016;153–9.
17.
Mancilla E, Brodsky J, Mehta S, Pignolo R, Levine M. Teriparatide as a systemic treatment for lower extremity nonunion fractures: a case series. Endocr Pract. 2015;136–42.
18.
Nishitani K, Mietus Z, Beck C, Ito H, Matsuda S, Awad H, et al. High dose teriparatide (rPTH1-34) therapy increases callus volume and enhances radiographic healing at 8-weeks in a massive canine femoral allograft model. PLoS One. 2017;185446.
19.
Ciurlia E, Leali P, Doria C. Use of teriparatide off-label: our experience and review of literature. Clin Cases Miner Bone Metab. 2017;28–34.
20.
Pietrogrande L, Raimondo E. Teriparatide in the treatment of non-unions: scientific and clinical evidences. Injury. 2013;(Suppl 1):54–7.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.